Cvs Health Corp Stock Price, News & Analysis

Thermo Fisher Scientific (NYSE:TMO) has announced the election of Karen S. Lynch to its board of directors, effective February 19, 2025. This appointment increases the board's size to 12 members. Lynch, the former president and CEO of CVS Health , brings over three decades of healthcare industry experience. During her tenure at CVS Health, she led more than 300,000 employees and oversaw operations reaching over 120 million consumers through healthcare benefits, pharmacy benefits management, and 9,000+ community health locations.

Lynch's extensive career includes executive positions at Aetna, Magellan Health Services, and Cigna She began her career as a CPA at Ernst & Young LLP and has served on the boards of CVS Health and U.S. Bancorp.

CVS Health (NYSE: CVS) has appointed Ed DeVaney as president of CVS Caremark, its pharmacy benefit management business, following his interim role since December 2024. DeVaney, who will report to Group President Prem Shah, brings extensive experience from his 20-year tenure with the company.

DeVaney previously led CVS Caremark sales and account management as president of Employer & Health Plans, where he was responsible for growing and maintaining the customer base across PBM lines of business. His role included oversight of government services, coalitions, and the PBM Marketing team.

Prior to joining CVS Health in 2005, DeVaney managed client relationships at Hewitt Associates, specializing in healthcare consulting and benefits administration. His appointment comes with a focus on making prescription drugs more affordable and enhancing drug pricing transparency through innovation.

CVS Health reported Q4 2024 results with total revenues increasing 4.2% to $97.7 billion. Full-year revenues rose 4.2% to $372.8 billion. However, Q4 GAAP diluted EPS decreased to $1.30 from $1.58, and Adjusted EPS fell to $1.19 from $2.12.

The company's Health Care Benefits segment faced challenges, with an adjusted operating loss of $439 million in Q4, compared to income of $676 million in the prior year. This decline was primarily due to increased utilization and unfavorable Medicare Advantage star ratings impact.

For 2025, CVS provided guidance with GAAP diluted EPS range of $4.58 to $4.83, Adjusted EPS of $5.75 to $6.00, and expected cash flow from operations of approximately $6.5 billion.

Twentyeight Health, a digital-first women's healthcare platform, has announced a collaboration with Aetna Better Health® of Illinois, a CVS Health company (NYSE: CVS). The partnership enables Aetna Better Health of Illinois members to access reproductive and sexual healthcare services through Twentyeight Health's telehealth platform at no cost through their health plan coverage.

The platform offers comprehensive women's health services, including family planning, birth control prescriptions, STI treatments, and pregnancy care. Members can connect with healthcare providers online, receive medication delivery, and benefit from unlimited messaging in Spanish and English. Appointments are typically available within one business day.

Operating in 43 states, Twentyeight Health is among the few digital-first women's healthcare platforms accepting Medicaid, focusing on providing accessible and affordable care, particularly for historically underserved communities.

CVS Health (NYSE: CVS) has launched the new CVS Health app, succeeding the CVS Pharmacy app, designed to streamline healthcare management and improve customer experience. The app integrates multiple features including family prescription management across CVS Pharmacy stores, Caremark mail orders, and Specialty pharmacies, immunization scheduling, and health spending tracking for eligible Caremark and Aetna members.

Key features include faster in-store prescription pickups via personalized barcodes, AI-powered search functionality, and a redesigned home screen with personalized health recommendations. The app also provides wellness content through partnerships with Everyday Health and Headspace. Future enhancements planned for 2025 include personalized recommendations for chronic condition management, conversational AI chat, and enhanced integration with Aetna and Caremark services.

With 60 million digital customers, CVS Health aims to make healthcare more accessible, affordable, and convenient through this comprehensive digital solution.

CVS Health Foundation has announced a $4 million grant initiative over five years to support healthy aging programs across four U.S. cities. The funding will be distributed equally ($1 million each) to organizations in Atlanta, Chicago, New York City, and Boynton Beach, focusing on improving healthcare access and resources for aging community members with brain, heart, and behavioral conditions.

The initiative responds to demographic shifts, as Census Bureau projections indicate that by 2034, Americans over 64 will outnumber those under 18. The grants will support various programs including Atlanta's Community Resource Hub, Chicago's Center for Better Aging's coordinated care model, New York's Care Your Way telemedicine initiative, and Boynton Beach's caregiver support program.

Each recipient organization will focus on specific local needs, from providing medically tailored meals and educational services to establishing data systems for tracking health outcomes and expanding telemedicine infrastructure.

CVS Health (NYSE: CVS) has announced it will host a conference call with analysts and investors on Wednesday, February 12th, 2025, at 8:00 a.m. ET. The call will discuss the company's fourth quarter and full year 2024 financial results. The event will be accessible via audio webcast on the Investor Relations section of CVS Health's website at investors.cvshealth.com, where it will remain archived for one year.

CVS Health (NYSE: CVS) has implemented comprehensive measures to support communities affected by California wildfires. CVS Pharmacy stores are reopening where safe, with pharmacy lines rerouted to nearby locations to ensure prescription access. The company is enabling one-time emergency 30-day medication refills through CVS Caremark for plan members in impacted areas.

CVS Specialty is actively contacting patients to arrange alternate delivery arrangements and medication access. Aetna has expanded its clinical response teams for Medicare and Commercial members, allowing emergency care access anywhere needed. The company has also extended its Resources For Living (RFL) services, offering mental health support and community resources through a dedicated crisis support line at 1-833-327-AETNA.

Zydus Lifesciences has announced an agreement with CVS Caremark to include its diabetes medications Zituvio™, Zituvimet™, and Zituvimet™ XR in CVS's template formulary starting January 1, 2025. These products, containing sitagliptin and metformin hydrochloride, are approved by the FDA through the 505(b)(2) route for improving glycemic control in adults with type 2 diabetes mellitus.

The medications work through DPP-4 inhibition and as biguanides, serving as an adjunct to diet and exercise. According to IQVIA™ data (MAT Aug-2023), the U.S. market for DPP-IV inhibitors and their combinations is valued at US$ 10 billion. This partnership represents a significant opportunity for Zydus to expand its presence in the U.S. market with its differentiated product portfolio.